Showing 36,902 results

Filters
Chemsex & recreational drug use

Changes to UK Steroid Laws

Editor's pick
Injecting Advice
23 April 2012
Epidemiology & behaviour

Study: Craigslist Drives STD Spread

Editor's pick
Investor Place
23 April 2012
New & experimental hepatitis C treatment

Achillion Announces 94 - 100% Complete EVR From Phase 2 Trial With ACH-1625 Based Regimen in Hepatitis C

Editor's pick
Achillion (press release)
23 April 2012
New & experimental hepatitis C treatment

Achillion Clarifies End of Treatment Data From Phase 2a Trial With ACH-1625 Based Regimen in Hepatitis C

Editor's pick
Achillion (press release)
23 April 2012
PrEP

The 100 Most Influential People in the World: Robert Grant

Editor's pick
Time
23 April 2012
New & experimental hepatitis C treatment

Pancreatitis Forces Halt to HCV Drug Trial

Editor's pick
MedPage Today
20 April 2012
New & experimental hepatitis C treatment

Janssen Creates new Division to Launch TMC435 and Help Conquer Hepatitis C in EMEA

Editor's pick
Janssen press release
20 April 2012
New & experimental HIV treatments

Cobicistat Doubles to Triples Exposure of GS-7340 (a Tenofovir Prodrug) and Resulting Tenofovir

Editor's pick
NATAP
20 April 2012
Undetectable viral load & treatment as prevention

Guidance on couples HIV testing and counselling, including antiretroviral therapy for treatment and prevention in serodiscordant couples

Editor's pick
World Health Organization
20 April 2012
New & experimental hepatitis C treatment

No Relevant Interactions Between Telaprevir and Two Newest Nonnucleosides Rilpivirine & Etravirine

Editor's pick
NATAP
20 April 2012
New & experimental hepatitis C treatment

Investigational Compound Peginterferon Lambda Achieved SVR24 Rates Comparable to Peginterferon Alfa with Fewer Flu-Like and Musculoskeletal Symptoms in Phase IIb Study in Treatment-Naive Genotype 2 or 3 Hepatitis C Patients

Editor's pick
BMS press release
20 April 2012
New & experimental hepatitis C treatment

Boehringer Ingelheim Hepatitis C Drugs Cured 82% in Trial

Editor's pick
Bloomberg
20 April 2012
New & experimental hepatitis C treatment

Medivir Hep C Drug Cures 80% of Patients Post-Treatment

Editor's pick
Bloomberg BusinessWeek
20 April 2012
New & experimental hepatitis C treatment

Gilead’s Experimental Hepatitis C Drug Cured 88% Post-Therapy

Editor's pick
Bloomberg
20 April 2012
New & experimental hepatitis C treatment

Gilead, Bristol hepatitis C trial data impresses

Editor's pick
Reuters
20 April 2012
Global health initiatives

Can the Global Fund's new management change its fortunes?

Editor's pick
The Guardian
20 April 2012
New & experimental hepatitis C treatment

Gilead, Bristol-Myers Squibb Put Profits Ahead of Best Care for Hep C Patients

Editor's pick
The Street
20 April 2012
Money

UK: NAT launches new report on HIV social care spending and services

Editor's pick
NAT press release
20 April 2012
Harm reduction

Naloxone Debate: FDA Hears Testimony About Making an Opioid Overdose Antidote Nonprescription

Editor's pick
Time
19 April 2012
Global health initiatives

Roadmap to be established towards greater efficiency, effectiveness and sustainability of national AIDS programmes

Editor's pick
International AIDS Society
18 April 2012
Access to healthcare

Kenya: Aids medicine stocks run low as donors start to close their taps

Editor's pick
Daily Nation
18 April 2012
Finance & funding

Canada to Slash Aid to 12 Countries

Editor's pick
All Africa
18 April 2012
Behaviour change interventions

India - Living in a train, living their dream

Editor's pick
DNA
18 April 2012
Activism & civil society

2012 Omololu Falobi Award for Excellence in HIV Prevention Research Community Advocacy Presented to Longtime Advocate Anna Forbes

Editor's pick
PR Newswire
18 April 2012